Stock information

 

Be invited to scroll down for detailed information regarding the Evotec AG share, ranging from basic share data to our dividend policy.  

Basic share data

Security identification numbers:
Frankfurt Stock Exchange
(ordinary bearer shares)
ISIN: DE0005664809
OTC Markets, OTCBB
(American Depositary Shares, ADSs)
CUSIP: 30050E105
ISIN: US30050E1055

Ticker symbol:
Frankfurt Stock Exchange: EVT
OTC Markets, OTCBB: EVTCY

Bloomberg Xetra: EVT GY Equity

Bloomberg OTC Markets, OTCBB: EVTCY US Equity
Reuters Xetra: EVTG.DE

Stock exchange:
Frankfurt Stock Exchange
OTC Markets, OTCBB

Segment:
Prime Standard

Index:
TecDAX, Prime All Share, LTecDAX, Technology All Share, CDAX

Designated sponsor:
ODDO SEYDLER BANK AG

Number of shares issued:
147,551,840  ordinary bearer shares

Nominal capital:
€ 147,551,840

Security identification numbers:
Frankfurt Stock Exchange
(ordinary bearer shares)
ISIN: DE0005664809
OTC Markets, OTCBB
(American Depositary Shares, ADSs)
CUSIP: 30050E105
ISIN: US30050E1055
 

Ticker symbol:
Frankfurt Stock Exchange: EVT
OTC Markets, OTCBB: EVTCY

Bloomberg Xetra: EVT GY Equity

Bloomberg OTC Markets, OTCBB: EVTCY US Equity
Reuters Xetra: EVTG.DE

 

Stock exchange:
Frankfurt Stock Exchange
OTC Markets, OTCBB

 

Segment:
Prime Standard

 

Index:
TecDAX, Prime All Share, LTecDAX, Technology All Share, CDAX

 

Designated sponsor:
ODDO SEYDLER BANK AG

 

Number of shares issued:
147,551,840  ordinary bearer shares

 

Nominal capital:
€ 147,551,840

 

Share price summary 2017 (XETRA)

High (04 Oct):
€ 22.50
Low (09 Feb):
€ 6.91
Opening Price:
€ 7.46
Closing Price:
€ 13.50
Weighted average number of shares outstanding:
145,009,742
Total number of shares outstanding as at 31 Dec:
147,532,681
Average daily trading volume (all exchanges):
1,662,539 shares
Market capitalisation as at 31 Dec:
€ 1,991.7 m
Earnings per share (diluted/basic):
€ 0.16/€ 0.17
Dividend per share:
€ 0.00
High (04 Oct):
€ 22.50
 
Low (09 Feb):
€ 6.91
 
Opening Price:
€ 7.46
 
Closing Price:
€ 13.50
 
Weighted average number of shares outstanding:
145,009,742
 
Total number of shares outstanding as at 31 Dec:
147,532,681
 
Average daily trading volume (all exchanges):
1,662,539 shares
 
Market capitalisation as at 31 Dec:
€ 1,991.7 m
 
Earnings per share (diluted/basic):
€ 0.16/€ 0.17
 
Dividend per share:
€ 0.00
 

Stock Price & Chart

 

Shareholder structure

As of 31 July 2018, the number of total voting rights amounts to 147,551,840.

Under the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG), shareholders of a listed German company are required to notify the Company and the German Federal Financial Supervisory Authority (BaFin) of any change to the voting interest in Evotec AG whenever it reaches, exceeds or falls below specified thresholds (3%, 5%, 10%, 15%, 20%, 25%, 30%, 50% or 75% of the voting rights). Evotec’s voting rights announcements can be found at dgap.de.

Three major shareholders, Novo Holdings A/S, ROI Verwaltungsgesellschaft mbH/Roland Oetker and Deutsche Asset Management Investment GmbH ("DAMI") have exceeded the threshold of 5%. The free float according to the definition of the Frankfurt Stock Exchange is approx. 65% according to our estimates (Evotec: 08/2018).

 

Shareholder structure (in %)

Most recent voting rights announcements

Date of the notification
Name of the person/company subject to the notification obligation
13 August 2018
Allianz Global Investors GmbH
10 August 2018
Allianz Global Investors GmbH
18  April 2018
JPMorgan Chase
17 April 2018
JPMorgan Chase
18 January 2018
Deutsche Asset Management Investment GmbH
Date of the notification 13 August 2018
Name of the person/company subject to the notification obligation Allianz Global Investors GmbH
Date of the notification 10 August 2018
Name of the person/company subject to the notification obligation Allianz Global Investors GmbH
Date of the notification 18  April 2018
Name of the person/company subject to the notification obligation JPMorgan Chase
Date of the notification 17 April 2018
Name of the person/company subject to the notification obligation JPMorgan Chase
Date of the notification 18 January 2018
Name of the person/company subject to the notification obligation Deutsche Asset Management Investment GmbH

 

Financial analysts

Overview of analysts covering the Evotec share

Bankhaus Lampe Volker Braun Bankhaus Lampe KG Jägerhofstraße 10 40479 Düsseldorf Germany

Joh. Berenberg, Gossler & Co. KG Klara H. Fernandes Joh. Berenberg, Gossler & Co. KG 60 Threadneedle Street London EC2R 8HP United Kingdom

Deutsche Bank Falko Friedrichs Gunnar Romer gunnar.romer@db.com Deutsche Bank AG Große Gallusstraße 10-14 60311 Frankfurt am Main Germany

EQUI.TS GmbH Thomas Schießle EQUI.TS GmbH Am Schieferstein 1 60435 Franfkurt am Main Germany

goetzpartners securities Limited Martin Brunninger Dr Tim Franklin tim.franklin@goetzpartners.com goetzpartners securities Limited The Stanley Building 7 Pancras Square London N1C 4AG United Kingdom

Kempen & Co. N.V. Anastasia Karpova Alexandru Cogut alexandru.cogut@kempen.com Kempen & Co. N.V. Beethovenstraat 300 P.O. Box 75666 1070 AR Amsterdam The Netherlands

ODDO BHF Igor Kim ODDO BHF Bockenheimer Landstraße 10 60323 Frankfurt am Main Germany

Rx Securities Dr Samir Devani Rx Securities Third Floor 1 Fore Street, Moorgate London EC2Y 9DT United Kingdom

 

Important note:

Evotec is monitored and assessed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Evotec’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Evotec or its management. Evotec does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Evotec has no obligation to update or supplement the above information and makes no representation or warranty as to the accuracy and completeness of this list.

Copies of the research reports of the above-named analysts must be obtained directly from the analysts or their employers. Evotec is not able to publish the research reports due to legal considerations.

Initial public offering information*

 

  • Segment: Neuer Markt, Frankfurt Stock Exchange
  • Offering structure: Public Offering in Germany, Private placement outside Germany, Rule 144A offering in the USA
  • Offer shares: 4,927,500 Offer shares each with an imputed share in the capital stock of € 1.00 per share, of which:
    4,100,000 New shares issued from a capital increase
    182,500 Shares sold by the selling shareholder
    645,00 Over-Allotment option from a capital increase
  • Global coordinators: UBS Warburg AG, Deutsche Bank AG
  • Further managers: SG Investment Banking, Sal. Oppenheim, Hamburger Sparkasse
  • Bookbuilding period: 02 November 1999 - 08 November 1999
  • Offering price: € 13.00
  • Listing: 10 November 1999
  • Opening price: € 24.00
  • Subscribed capital: € 12,078,000

*All data not adjusted for stock split of 18 August 2000

Dividend

Payment of dividends is dependent upon Evotec AG’s financial situation and liquidity requirements, the general market conditions and statutory, tax and regulatory requirements. Evotec currently intends to retain any potential future profits and reinvest them in the Company’s further growth strategy.

 

 

Contact us

Gabriele Hansen

VP, Corporate Communications & Investor Relations

T +49 40 560 81 255 F +49 40 560 81 333 vCard

Katja Werner

Investor Relations Associate

T +49 40 560 81 210 F +49 40 560 81 333 vCard
TOP